Cytek Biosciences
(NASDAQ) CTKB
Cytek Biosciences Financials at a Glance
Market Cap
$511.41M
Revenue (TTM)
$204.17M
Net Income (TTM)
$74.00M
EPS (TTM)
$-0.58
P/E Ratio
-6.86
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$3.97
Volume
21,639
Open
$3.69
Price
$3.97
Volume
21,639
Open
$3.69
Previous Close
$3.97
Daily Range
$3.65 - $3.98
52-Week Range
$2.37 - $6.18
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$3.97
Volume
21,639
Open
$3.69
Previous Close
$3.97
Daily Range
$3.65 - $3.98
52-Week Range
$2.37 - $6.18
CTKB News
CTKB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cytek Biosciences
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
700
CEO
Wen Bin Jiang, PhD
Website
cytekbio.comHeadquarters
Fremont, CA 94538, US
CTKB Financials
Key Financial Metrics (TTM)
Gross Margin
52%
Operating Margin
-21%
Net Income Margin
-36%
Return on Equity
-21%
Return on Capital
-12%
Return on Assets
-16%
Earnings Yield
-14.58%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$511.41M
Shares Outstanding
129.14M
Volume
21.64K
Avg. Volume
792.32K
Financials (TTM)
Gross Profit
$104.46M
Operating Income
$40.38M
EBITDA
$17.39M
Operating Cash Flow
$4.69M
Capital Expenditure
$4.08M
Free Cash Flow
$8.77M
Cash & ST Invst.
$261.53M
Total Debt
$23.74M
Cytek Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$44.13M
+6.5%
Gross Profit
$21.25M
+5.4%
Gross Margin
48.16%
N/A
Market Cap
$511.41M
N/A
Market Cap/Employee
$771.35K
N/A
Employees
663
N/A
Net Income
$18.87M
-65.5%
EBITDA
$15.65M
-93.4%
Quarterly Fundamentals
Net Cash
$225.90M
-9.5%
Accounts Receivable
$56.48M
+2.3%
Inventory
$49.79M
+9.8%
Long Term Debt
$20.46M
+144.6%
Short Term Debt
$15.86M
+110.6%
Return on Assets
-16.48%
N/A
Return on Invested Capital
-11.92%
N/A
Free Cash Flow
$4.90M
-402.5%
Operating Cash Flow
$2.74M
-2088.8%